Showing results (491-500 of 589) with videos related to

Sort By:
Pageof 59
Human Molecular Genetics|May 20, 2022
A randomized controlled trial of everolimus for neurocognitive symptoms in PTEN hamartoma tumor syndromeSiddharth Srivastava, Booil Jo, Bo Zhang, et al.
American Journal of Human Genetics|July 5, 2003
Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathwayXiao-Ping Zhou, Kristin A Waite, Robert Pilarski, et al.
Chemrxiv : the Preprint Server for Chemistry|July 18, 2020
A Network Medicine Approach to Investigation and Population-based Validation of Disease Manifestations and Drug Repurposing for COVID-19Yadi Zhou, Yuan Hou, Jiayu Shen, et al.
Human Mutation|October 13, 2018
Gene-specific criteria for PTEN variant curation: Recommendations from the ClinGen PTEN Expert PanelJessica L Mester, Rajarshi Ghosh, Tina Pesaran, et al.
Gastroenterology|February 13, 2013
Prevalence of germline PTEN, BMPR1A, SMAD4, STK11, and ENG mutations in patients with moderate-load colorectal polypsJoanne Ngeow, Brandie Heald, Lisa A Rybicki, et al.
Plos Biology|November 6, 2020
A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19Yadi Zhou, Yuan Hou, Jiayu Shen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2009
A multi-institutional phase II study of the efficacy and tolerability of lapatinib in patients with advanced hepatocellular carcinomasTanios Bekaii-Saab, Joseph Markowitz, Nichole Prescott, et al.
The American Journal of Surgical Pathology|March 27, 2012
PTEN hamartoma of soft tissue: a distinctive lesion in PTEN syndromesKyle C Kurek, Emily Howard, L B Tennant, et al.
Cell Reports|November 30, 2022
Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer's diseaseJielin Xu, Chengsheng Mao, Yuan Hou, et al.
Annals of Surgical Oncology|June 7, 2013
International rates of breast reconstruction after prophylactic mastectomy in BRCA1 and BRCA2 mutation carriersJohn Semple, Kelly A Metcalfe, Henry T Lynch, et al.
Pageof 59